Page 636 - Read Online

Adeyemi et al. J Cancer Metastasis Treat 2018;4:53 I http://dx.doi.org/10.20517/2394-4722.2018.12 Page 7 of 8

Consent for publication
The study didn’t make use of patients directly but through secondary data collection method. The patients
already gave their consent before they went through radiotherapy.

Copyright
© The Author(s) 2018.

REFERENCES
1. Assi HA, Khoury KE, Dbouk H, Khalil LE, Mouhieddine TH, El Saghir NS. Epidemiology and prognosis of breast cancer in young women.
J Thorac Dis 2013; doi: 10.3978/j.issn.2072-1439.2013.05.24.
2. Olajide TO, Ugburo AO, Habeebu MO, Lawal AO, Afolayan MO, Mofikoya MO. Awareness and practice of breast screening and its impact
on early detection and presentation among breast cancer patients attending a clinic in Lagos, Nigeria. Niger J Clin Pract 2014;17:802-7.
3. Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brønnum D, Correa C, Cutter D, Gagliardi G, Gigante B, Jensen MB,
Nisbet A, Peto R, Rahimi K, Taylor C, Hall P. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med
2013;368:987-98.
4. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh
T, Peto R, Taylor C, Wang Y; Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of radiotherapy and of differences
in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet
2005;366:2087-106.
5. Fowble B, Hanlon A, Freedman G, Nicolaou N, Anderson P. Second cancers after conservative surgery and radiation for stages I-II breast
cancer: identifying a subset of women at increased risk. Int J Radiat Oncol Biol Phys 2001;51:679-90.
6. Raymond JS, Hogue CJ. Multiple primary tumours in women following breast cancer, 1973-2000. Br J Cancer 2006;94:1745-50.
7. Mellemkjaer L, Friis S, Olsen JH, Scélo G, Hemminki K, Tracey E, Andersen A, Brewster DH, Pukkala E, McBride ML, Kliewer EV,
Tonita JM, Kee-Seng C, Pompe-Kirn V, Martos C, Jonasson JG, Boffetta P, Brennan P. Risk of second cancer among women with breast
cancer. Int J Cancer 2006;118:2285-92.
8. Brown LM, Chen BE, Pfeiffer RM, Schairer C, Hall P, Storm H, Pukkala E, Langmark F, Kaijser M, Andersson M, Joensuu H, Fosså SD,
Travis LB. Risk of second non-hematological malignancies among 376,825 breast cancer survivors. Breast Cancer Res tr 2007;106:439-51.
9. Tubiana M. Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncol
2009;91:4-15.
10. Rubino C, de Vathaire F, Diallo I, Shamsaldin A, Lê MG. Increased risk of second cancers following breast cancer: role of the initial
treatment. Breast Cancer Res Treat 2000;61:183-95.
11. Rubino C, de Vathaire F, Shamsaldin A, Labbe M, Lê MG. Radiation dose, chemotherapy, hormonal treatment and risk of second cancer
after breast cancer treatment. Br J Cancer 2003;89:840-6.
12. Zhang W, Becciolini A, Biggeri A, Pacini P, Muirhead CR. Second malignancies in breast cancer patients following radiotherapy: a study in
Florence, Italy. Breast Cancer Res 2011;13:R38.
13. Zhang W, Becciolini A, Biggeri A, Pacini P, Muirhead CR. Region of treatment in radiotherapy and second malignancies in breast cancer
patients. J Cancer Therapy 2012;3:768-76.
14. Donovan EM, James H, Bonora M, Yarnold JR, Evans PM. Second cancer incidence risk estimates using BEIR VII models for standard and
complex external beam radiotherapy for early breast cancer. Med Phys 2012;39:5814-24.
15. Johansen S, Danielsen T, Olsen DR. Estimated risk for secondary cancer in the contra-lateral breast following radiation therapy of breast
cancer. Acta Oncol 2008;47:391-6.
16. Niemierko, A. (1999) A Generalized Concept of Equivalent Uniform Dose (EUD). Available from: http://www.scirp.org/
(S(lz5mqp453edsnp55rrgjct55))/reference/ReferencesPapers.aspx?ReferenceID=1679390. [Last accessed on 30 Sep 2018]
17. Niemierko A. Reporting and analyzing dose distributions: a concept of equivalent uniform dose. Med phys 1997;24:103-10.
18. Webb S, Nahum AE. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous
distributions of dose and clonogenic cell density. Phys Med Biol 1993;38:653-66.
19. Schneider U, Zwahlen D, Ross D, Kaser-Hotz B. Estimation of radiation-induced cancer from three-dimensional dose distributions: concept
of organ equivalent dose. Int J Radiat Oncol Biol Phys 2005;61:1510-5.
20. Abo-Madyan Y, Aziz MH, Aly MM, Schneider F, Sperk E, Clausen S, Giordano FA, Herskind C, Steil V, Wenz F, Glatting G. Second cancer
risk after 3D-CRT, IMRT and VMAT for breast cancer. Radiother Oncol 2014;110:471-6.
21. Schneider U1, Kaser-Hotz B. A simple dose-response relationship for modeling secondary cancer incidence after radiotherapy. Z Med Phys
2005;15:31-7.
22. Schneider U, Kaser-Hotz B. Radiation risk estimates after radiotherapy: application of the organ equivalent dose concept to plateau dose-
response relationships. Radiat Environ Biophys 2005;44:235-9.
23. Burt LM, Ying J, Poppe MM, Suneja G, Gaffney DK. Risk of secondary malignancies after radiation therapy for breast cancer:
comprehensive results. Breast 2017;35:122-9.
24. Berrington de Gonzalez A, Curtis RE, Gilbert E, Berg CD, Smith SA, Stovall M, Ron E. Second solid cancers after radiotherapy for breast
cancer in SEER cancer registries. Br J Cancer 2010;102:220-6.
25. Maddams J, Parkin DM, Darby SC. The cancer burden in the United Kingdom in 2007 due to radiotherapy. Int J Cancer 2011;129:2885-93.
26. Morton LM, Gilbert ES, Hall P, Andersson M, Joensuu H, Vaalavirta L, Dores GM, Stovall M, Holowaty EJ, Lynch CF, Curtis RE, Smith